HC Deb 12 February 1991 vol 185 cc423-4W
Sir Michael McNair-Wilson

To ask the Secretary of State for Health whether his Department has now approved a particular design for a powered wheelchair for the use of patients in hospital or suffering disability.

Mr. Dorrell

The Department provides an evaluation service to assist NHS prescribers, rather than approve wheelchairs for health service use, as such. Chemotherapy

Mr. Hardy

To ask the Secretary of State for Health if he will ensure that where use of the drug Ondansetron is judged clinically to be of help to patients receiving chemotherapy sufficient funding is available to enable it to be prescribed.

Mrs. Virginia Bottomley

Ondansetron is available for prescription by doctors throughout the national health service for the prevention of nausea and vomiting in patients undergoing chemotherapy and/or radiotherapy for cancer.

It is for the individual doctor to decide whether to prescribe Ondansetron, or indeed any drug, in a given set of circumstances. In many districts drug and therapeutic committees have been set up to secure the agreement and commitment of clinicians to an efficacious and economical system of drug usage and have drawn up formularies of preferred treatments. It is for health authorities to determine what financial allocation should be made available to any particular area of clinical care, including the provision of drugs.

Back to